| PERIOD ENDING | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | | Total Revenue | 8,141,000 | 8,209,000 | 8,430,000 | 8,816,000 | | Cost of Revenue | 4,061,000 | 4,026,000 | 4,122,000 | 4,224,000 | | | Gross Profit | 4,080,000 | 4,183,000 | 4,308,000 | 4,592,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 2,282,000 | 2,787,000 | 2,573,000 | 2,768,000 | | Non Recurring |
-
|
-
| 1,472,000 | (28,000) | | Others | 1,911,000 | 1,883,000 | 1,992,000 | 2,057,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (113,000) | (487,000) | (1,729,000) | (205,000) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
| 12,000 | 28,000 | | Earnings Before Interest And Taxes | (961,000) | (772,000) | (1,846,000) | (177,000) | | Interest Expense | (352,000) | 352,000 | 333,000 | 338,000 | | Income Before Tax | (609,000) | (1,124,000) | (2,179,000) | (515,000) | | Income Tax Expense | (225,000) | (530,000) | (558,000) | (189,000) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (815,000) | (594,000) | (1,621,000) | (326,000) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (384,000) | (594,000) | (1,621,000) | (326,000) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($384,000) | ($594,000) | ($1,621,000) | ($326,000) |
|
2.03% Nasdaq 0.00%
Income Statement
